Oncology & Cancer

First-in-class targeted microRNA therapy slows cancer tumor growth

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported in Oncogene, tumors treated with the ...

Immunology

Nanobodies from alpacas could steer immune attacks on influenza

While conventional flu vaccines are designed to anticipate the influenza strains projected to dominate in the next flu season, they're only partially effective. And while antiviral drugs are available to treat active flu ...

Oncology & Cancer

RNA stability may play a role in prostate cancer

Mutations in a genetic region that regulates RNA stability could influence prostate cancer outcomes and drug resistance, according to new work from scientists at Fred Hutchinson Cancer Center published in Cell Reports.

Oncology & Cancer

Uncovering why some cells become resistant to anti-cancer therapies

A research team led by Northwestern University and the University of Pennsylvania scientists has created a new synthetic biology approach, a "QR code for cancer cells," to follow tumor cells over time, finding there are meaningful ...

page 7 from 40